Avani Dave, Jai Hind College A recent study conducted by Satveer Mahil et al., showcased in the current year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published in The Lancet Rheumatology, demonstrates that it is not the response of T-cell but that of the antibody to the first jab of the Pfizer […]
Rohit Bhattacharjee, Amity University Kolkata Although inhibition of T cell co-inhibitory receptors has brought about cancer therapy, mechanisms governing their expression on human T cells have not been explained. Type 1 interferon (IFN-I) regulates T cell immunity in viral infection, autoimmunity, cancer, and may enhance induction of T cell exhaustion in chronic viral infection. To […]
Subhangi Das, Bankura Sammilani College With the phototherapic development which is also a type of light-induced treatment of cancer, several biomaterials are newly designed as photo-absorbing /sensitizing agents or effecting carriers to enhance the therapeutic efficacy and effective nature of phototherapy. Recently, the immune system responses produced by phototherapy. Which have been explored widely and […]
